We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+12.55%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$829M
AUM Growth
+$50.1M
Cap. Flow
-$19M
Cap. Flow %
-2.29%
Top 10 Hldgs %
10.48%
Holding
750
New
132
Increased
82
Reduced
213
Closed
129

Top Sells

Rank Stock Value
1
ROST icon
Ross Stores
ROST
+$7.44M
2
GEN icon
Gen Digital
GEN
+$6.22M
3
HUM icon
Humana
HUM
+$6.1M
4
STX icon
Seagate
STX
+$6.08M
5
UTHR icon
United Therapeutics
UTHR
+$6.04M

Sector Composition

Rank Sector Weight
1 Healthcare 14.13%
2 Consumer Discretionary 14.03%
3 Financials 12.26%
4 Industrials 11.76%
5 Technology 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WST icon
151
West Pharmaceutical
WST
$23.7B
$1.41M 0.17%
28,837
-1,543
-5% -$72.2K
OC icon
152
Owens Corning
OC
$11B
$1.41M 0.17%
34,621
-85,368
-71% -$3.24M
FIX icon
153
Comfort Systems
FIX
$53.5B
$1.4M 0.17%
72,069
+71,746
+22,212% +$1.36M
TYL icon
154
Tyler Technologies
TYL
$13.7B
$1.39M 0.17%
13,566
-286
-2% -$27.8K
BCC icon
155
Boise Cascade
BCC
$2.73B
$1.37M 0.17%
46,612
+5,540
+13% +$145K
SPNT icon
156
SiriusPoint
SPNT
$3.03B
$1.37M 0.17%
+74,082
New +$1.19M
KS
157
DELISTED
KapStone Paper and Pack Corp.
KS
$1.36M 0.16%
48,744
-3,408
-7% -$86.2K
OWW
158
DELISTED
ORBITZ WORLDWIDE, INC
OWW
$1.35M 0.16%
187,838
+21,699
+13% +$170K
AOS icon
159
A.O. Smith
AOS
$8.55B
$1.34M 0.16%
49,864
-2,868
-5% -$73.5K
PDLI
160
DELISTED
PDL BioPharma, Inc.
PDLI
$1.33M 0.16%
158,256
-300
-0.2% -$2.53K
EFII
161
DELISTED
Electronics for Imaging
EFII
$1.33M 0.16%
+34,400
New +$1.25M
UTHR icon
162
United Therapeutics
UTHR
$26.1B
$1.33M 0.16%
11,763
-67,024
-85% -$6.04M
MMS icon
163
Maximus
MMS
$3.32B
$1.33M 0.16%
30,157
-1,775
-6% -$81.8K
AVTA
164
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.32M 0.16%
+45,400
New +$1.23M
GNTX icon
165
Gentex
GNTX
$5.1B
$1.32M 0.16%
80,194
+80,092
+78,522% +$1.17M
RLJ icon
166
RLJ Lodging Trust
RLJ
$1.88B
$1.31M 0.16%
54,000
+1,910
+4% +$46K
WNR
167
DELISTED
Western Refining Inc
WNR
$1.31M 0.16%
30,971
-15,800
-34% -$567K
EME icon
168
Emcor
EME
$29.9B
$1.29M 0.16%
30,398
-16,413
-35% -$640K
FSS icon
169
Federal Signal
FSS
$6.82B
$1.29M 0.16%
87,910
-5,420
-6% -$77.3K
MAGN
170
Magnera Corp
MAGN
$493M
$1.28M 0.15%
3,558
-198
-5% -$70.2K
DEI icon
171
Douglas Emmett
DEI
$2.05B
$1.26M 0.15%
54,167
-4,963
-8% -$118K
EXP icon
172
Eagle Materials
EXP
$6.49B
$1.26M 0.15%
16,295
-5,954
-27% -$448K
GLRE icon
173
Greenlight Captial
GLRE
$579M
$1.26M 0.15%
37,398
+37,351
+79,470% +$1.17M
VAC icon
174
Marriott Vacations Worldwide
VAC
$3.53B
$1.25M 0.15%
23,760
-1,110
-4% -$55.8K
LSI
175
DELISTED
Life Storage, Inc.
LSI
$1.24M 0.15%
28,509
+1,818
+7% +$85.7K

Similar funds

Globeflex Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Globeflex Capital held 750 positions worth $829M, up 6.4% from $779M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Globeflex Capital's Q4 2013 filing shows 132 new, 82 increased, 213 reduced and 129 closed positions. Its largest new stake was DOMTAR CORPORATION (New): 141,698 shares worth $6.68M. The largest sale was Ross Stores, an estimated $7.44M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Globeflex Capital's largest Q4 2013 buy was DOMTAR CORPORATION (New): 141,698 shares worth $6.68M.
  • Globeflex Capital added most to Huntington Ingalls Industries in Q4 2013, an estimated $5.24M increase.
  • Globeflex Capital's biggest Q4 2013 reduction was United Therapeutics, cutting an estimated $6.04M.
  • Globeflex Capital fully exited Ross Stores in Q4 2013, selling an estimated $7.44M.
  • Globeflex Capital's ten largest holdings make up 10% of its $829M portfolio in Q4 2013.
  • Globeflex Capital opened 132 new positions and closed 129 in Q4 2013.
  • Globeflex Capital's portfolio value rose 6.4% quarter-over-quarter to $829M.

Based on Globeflex Capital's 13F filing for Q4 2013, filed 12 Feb 2014.